PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAC Immune SA
AC Immune SA(ACIU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
neoplasms
,
lymphoma
,
large b-cell lymphoma diffuse
Gilvetmab
colorectal neoplasms
,
squamous cell neoplasms
,
sarcoma
,
head and neck neoplasms
,
pancreatic ductal carcinoma
,
triple negative breast neoplasms
,
mycoses
,
merkel cell carcinoma
,
mycosis fungoides
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neoplasm metastasis
,
pancreatic neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
bile duct neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
neoplasms
,
melanoma
,
renal cell carcinoma
,
ovarian neoplasms
,
urologic neoplasms
,
lung neoplasms
,
breast neoplasms
,
adenocarcinoma
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
peritoneal neoplasms
,
transitional cell carcinoma
,
neoadjuvant therapy
,
kidney diseases
,
urogenital neoplasms
,
kidney neoplasms
,
urologic diseases
,
neoplasms by site
,
glandular and epithelial neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
squamous cell carcinoma of head and neck
,
urinary bladder neoplasms
,
squamous cell carcinoma
,
non-muscle invasive bladder neoplasms
,
disease progression
Bevifimod
neoplasms
,
healthy volunteers/patients
,
non-small-cell lung carcinoma
Fludeoxyglucose f-18
type 2 diabetes mellitus
,
diabetes mellitus
,
healthy volunteers/patients
,
cardiomyopathies
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
type 1 diabetes mellitus
,
tobacco use disorder
,
hyperlipidemias
,
chronic obstructive pulmonary disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use